Disequilibrium with HLA-B*5703 Viremia Is Independent of Its Linkage Mediated Control of HIV - HLA-A*7401

The potential contribution of HLA-A alleles to viremic control in chronic HIV type 1 (HIV-1) infection has been relatively understudied compared with HLA-B. In these studies, we show that HLA-A*7401 is associated with favorable viremic control in extended southern African cohorts of >2100 C-clade–infected subjects. We present evidence that HLA-A*7401 operates an effect that is independent of HLA-B*5703, with which it is in linkage disequilibrium in some populations, to mediate lowered viremia. We describe a novel statistical approach to detecting additive effects between class I alleles in control of HIV-1 disease, highlighting improved viremic control in subjects with HLA-A*7401 combined with HLA-B*57. In common with HLA-B alleles that are associated with effective control of viremia, HLA-A*7401 presents highly targeted epitopes in several proteins, including Gag, Pol, Rev, and Nef, of which the Gag epitopes appear immunodominant. We identify eight novel putative HLA-A*7401–restricted epitopes, of which three have been defined to the optimal epitope. In common with HLA-B alleles linked with slow progression, viremic control through an HLA-A*7401–restricted response appears to be associated with the selection of escape mutants within Gag epitopes that reduce viral replicative capacity. These studies highlight the potentially important contribution of an HLA-A allele to immune control of HIV infection, which may have been concealed by a stronger effect mediated by an HLA-B allele with which it is in linkage disequilibrium. In addition, these studies identify a factor contributing to different HIV disease outcomes in individuals expressing HLA-B*5703. The Journal of Immunology , 2011, 186: 5675–5686.

[1]  Jerome H. Kim,et al.  Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania. , 2010, The Journal of infectious diseases.

[2]  C. Naugler.  Origins and relatedness of human leukocyte antigen class I allele supertypes. , 2010, Human immunology.

[3]  S. Buus,et al.  Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.

[4]  D. Heckerman,et al.  Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection , 2010, Journal of Virology.

[5]  P. Klenerman,et al.  Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa , 2009, Antiviral therapy.

[6]  B. Walker,et al.  Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection , 2009, Journal of Virology.

[7]  L. McKinnon,et al.  Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag. , 2009, AIDS.

[8]  B. Walker,et al.  Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients , 2009, The Journal of experimental medicine.

[9]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[10]  M. Nielsen,et al.  Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays , 2009, Journal of biomolecular screening.

[11]  M. Essex,et al.  Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein , 2008, Journal of Virology.

[12]  B. Agan,et al.  HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles , 2008, PloS one.

[13]  David Heckerman,et al.  Phylogenetic Dependency Networks: Inferring Patterns of CTL Escape and Codon Covariation in HIV-1 Gag , 2008, PLoS Comput. Biol..

[14]  C. Gray,et al.  Human Immunodeficiency Virus-Specific Gamma Interferon Enzyme-Linked Immunospot Assay Responses Targeting Specific Regions of the Proteome during Primary Subtype C Infection Are Poor Predictors of the Course of Viremia and Set Point , 2008, Journal of Virology.

[15]  Philip J. R. Goulder,et al.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.

[16]  David Heckerman,et al.  Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection , 2008, AIDS.

[17]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[18]  David Heckerman,et al.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.

[19]  Tanmoy Bhattacharya,et al.  HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load , 2008, Journal of Virology.

[20]  Todd M. Allen,et al.  Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid , 2008, Journal of Virology.

[21]  Winston A Hide,et al.  Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.

[22]  S. Oka,et al.  Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS. , 2008, Biochemical and biophysical research communications.

[23]  D. Heckerman,et al.  Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. , 2008, AIDS research and human retroviruses.

[24]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[25]  J. Borghans,et al.  HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24 , 2007, PLoS ONE.

[26]  Jacques Fellay,et al.  A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.

[27]  M. Altfeld,et al.  Availability of a Diversely Avid CD8+ T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p2419–27 Epitope1 , 2007, The Journal of Immunology.

[28]  Philip J. R. Goulder,et al.  Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.

[29]  E. Rosenberg,et al.  Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles , 2007, Journal of Virology.

[30]  B. Walker,et al.  Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.

[31]  G Thomson,et al.  PyPop update--a software pipeline for large-scale multilocus population genomics. , 2007, Tissue antigens.

[32]  D. Heckerman,et al.  Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.

[33]  D. Watkins,et al.  Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.

[34]  F. Pereyra,et al.  Control of Human Immunodeficiency Virus Type 1 Is Associated with HLA-B*13 and Targeting of Multiple Gag-Specific CD8+ T-Cell Epitopes , 2007, Journal of Virology.

[35]  M. Carrington,et al.  Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B12 , 2007, The Journal of Immunology.

[36]  David Heckerman,et al.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.

[37]  M. Hoelscher,et al.  CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients , 2006, Journal of Virology.

[38]  B. Walker,et al.  Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype , 2006, The Journal of Immunology.

[39]  B. Walker,et al.  Motif Inference Reveals Optimal CTL Epitopes Presented by HLA Class I Alleles Highly Prevalent in Southern Africa1 , 2006, The Journal of Immunology.

[40]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[41]  Andrew K. Sewell,et al.  Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA , 2005, The Journal of experimental medicine.

[42]  Bette Korber,et al.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.

[43]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[44]  Todd M. Allen,et al.  Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection , 2003, AIDS.

[45]  Derek Middleton,et al.  A new allele frequency database , 2002 .

[46]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[47]  P. Easterbrook,et al.  Complete mapping of a novel HLA A*6801-restricted HIV-1 Tat epitope directly with a rapid modified enzyme-linked immunospot assay. , 2002, AIDS.

[48]  M. Carrington,et al.  HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.

[49]  R. Kaul,et al.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. , 2001, The Journal of clinical investigation.

[50]  J. Sidney,et al.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.

[51]  H. Ullum,et al.  The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection , 1998, AIDS.

[52]  R. Phillips,et al.  Combined structural and immunological refinement of HIV‐1 HLA‐B8‐restricted cytotoxic T lymphocyte epitopes , 1997, European journal of immunology.

[53]  R. Phillips,et al.  Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[54]  P. Parham.  Immunology. Deconstructing the MHC. , 1992, Nature.